Literature DB >> 21775016

Laboratory diagnosis of Clostridium difficile infection: in a state of transition or confusion or both?

M H Wilcox1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21775016     DOI： 10.1016/j.jhin.2011.05.010

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  9 in total

1.  Clostridium difficile testing: have we got it right?

Authors:  Wei-Yuen Su; Joanne Mercer; Sebastiaan J Van Hal; Michael Maley
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

2.  Adherence to clinical practice guidelines for the management of Clostridium difficile infection in Japan: a multicenter retrospective study.

Authors:  K Kobayashi; N Sekiya; Y Ainoda; H Kurai; A Imamura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-02       Impact factor: 3.267

Review 3.  Clostridium difficile infection in patients with liver disease: a review.

Authors:  A Trifan; O Stoica; C Stanciu; C Cojocariu; A-M Singeap; I Girleanu; E Miftode
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-06       Impact factor: 3.267

4.  Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.

Authors:  P Rocco LaSala; Tariq Ekhmimi; A Kate Hill; Imran Farooqi; Peter L Perrotta
Journal:  J Clin Microbiol       Date:  2012-11-07       Impact factor: 5.948

5.  Towards point of care testing for C. difficile infection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection.

Authors:  N D McGuire; R J Ewen; B de Lacy Costello; C E Garner; C S J Probert; K Vaughan; N M Ratcliffe
Journal:  Meas Sci Technol       Date:  2014-05-12       Impact factor: 2.046

6.  Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.

Authors:  A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; Rosalind M Harding; Lily O'Connor; David Griffiths; Ali Vaughan; John Finney; Mark H Wilcox; Derrick W Crook; Tim E A Peto
Journal:  PLoS Med       Date:  2012-02-07       Impact factor: 11.069

7.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.

Authors:  Timothy D Planche; Kerrie A Davies; Pietro G Coen; John M Finney; Irene M Monahan; Kirsti A Morris; Lily O'Connor; Sarah J Oakley; Cassie F Pope; Mike W Wren; Nandini P Shetty; Derrick W Crook; Mark H Wilcox
Journal:  Lancet Infect Dis       Date:  2013-09-03       Impact factor: 25.071

8.  Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?

Authors:  Mark I Garvey; Craig W Bradley; Martyn A C Wilkinson; Elisabeth Holden
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-19       Impact factor: 4.887

9.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.